AVERT™ Clinical Trial for Contrast Media Volume Reduction and Incidence of CIN (AVERT™)

Trial ID or NCT#

NCT01976299

Status

not recruiting iconNOT RECRUITING

Purpose

The Osprey Medical AVERT System is indicated to reduce contrast media (CM) exposure to the kidneys during percutaneous coronary procedures thereby reducing the risk of contrast induced nephropathy (CIN).

Investigator(s)

David P. Lee, MD

View on ClinicalTrials.gov